BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

LIBRAINFU

All Eps Dividend Board Agm Q1 Q2 Q3

LIBRAINFU 06-Apr-2021

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has further informed that the meeting of the Board of Directors of the Company will now be held on April 12, 2021 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2019.

LIBRAINFU 08-Mar-2021

The Company has further informed that, due to unavoidable circumstances, the Board meeting as per LR 19(1), scheduled to be held on March 07, 2021 at 4:00 PM, to consider, among others, audited financial statements of the Company for the year ended on June 30, 2019, has been postponed. New date and time of the meeting will be notified later on.

LIBRAINFU 24-Feb-2021

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on March 07, 2021 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2019.

LIBRAINFU 02-Sep-2020

DSE NEWS: The Stock Brokers and Merchant Bankers are requested to abstain from providing loan facilities to purchase security of Libra Infusions Limited in between 1st to 30th trading day after change of categorization, with effect from Today, September 02, 2020 as per BSEC Directive No. SEC/CMRRCD/2009-193/177 and BSEC Order No. SEC/CMRRCD/2009-193/178 dated October 27, 2015.

LIBRAINFU 02-Sep-2020

As per BSEC, Letter No. SEC/SRMIC/94-231/51-8 dated September 01, 2020, the Company shall be placed in 'A' category from existing 'Z' category with effect from Today, September 02, 2020 in line with the provisions of Commission?s Order No. SEC/CMRRCD/2009-93/08 dated September 01, 2020.

LIBRAINFU 30-Dec-2019

The Stock Brokers and Merchant Bankers are requested to abstain from providing loan facilities to purchase security of Libra Infusions Limited with effect from January 01, 2020 as per BSEC Directive No. SEC/CMRRCD/2001-43/169 dated October 01, 2009.

LIBRAINFU 30-Dec-2019

The Company has been placed in 'Z' category from existing 'A' category with effect from January 01, 2020 as the Company has failed to hold AGM in the year 2019.

LIBRAINFU 28-Oct-2019

The Company has further informed that, due to certain unavoidable circumstances, the Board meeting as per LR 19(1), scheduled to be held on October 28, 2019 at 4:00 PM, to consider, among others, audited financial statements of the Company for the year ended on June 30, 2019, has been postponed. New date and time of the meeting will be notified later on.

LIBRAINFU 23-Oct-2019

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2019 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2019.

LIBRAINFU 25-Jun-2019

(Q3 Un-audited): EPS was Tk. (11.38) for January-March 2019 as against Tk. (12.13) for January-March 2018; EPS was Tk. (18.07) for July 2018-March 2019 as against Tk. (12.65) for July 2017-March 2018. NOCFPS was Tk. 2.84 for July 2018-March 2019 as against Tk. 9.70 for July 2017-March 2018. NAV per share was Tk. 1,309.82 as on March 31, 2019 and Tk. 1,565.31 as on March 31, 2018.

Previous Next page